Search Results

Saved Studies



 
Active, currently enrolling    Who can join   

Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US

Keywords: Risk Factors; Medical Conditions; Pathology; Blood; Urine; Natural History
Study Type: Prospective Cohort Study with Direct Patient Contact   |  Region: Georgia
Active, currently enrolling    Who can join   

S0820, Adenoma and Second Primary Prevention Trial (PACES)

Keywords: Oncology (Adult); S0820; Eflornithine/sulindac prevention…
Study Type: Clinical Trial   |  Region: California - Northern
Enrollment complete    Who can join   

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

Keywords: Oncology (Adult); NSABP-B-47; Breast Neoplasms; Neoplasms by…
Study Type: Clinical Trial   |  Region: California - Northern
Active, currently enrolling    Who can join   

A Phase 3, single-arm, open-label, multicenter study of the safety and efficacy of dirloctocogene samoparvovec (SPK-8011, adeno-associated viral vector with B-domain deleted human factor VIII gene) in adults with severe or moderately severe hemophilia A (KEYSTONE 1)

Keywords: Oncology (Adult);
Study Type: Clinical Trial   |  Region: California - Northern
Enrollment complete    Who can join   

Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: A Randomized Phase 3 Non-Inferiority Trial (IMAGINE)

Keywords: Oncology (Adult);
Study Type: Clinical Trial   |  Region: California - Northern
Active, currently enrolling    Who can join   

Phase 3, Open-Label, Randomized, Study Comparing Gedatolisib Combined With Fulvestrant & With or Without Palbociclib to Standard-of-Care Therapies in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination w/Non-SteroidalAromatase Inhibitor Therapy

Keywords: Oncology (Adult);
Study Type: Clinical Trial   |  Region: Hawaii
Enrollment complete    Who can join   

BO41843: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-9545 COMBINED WITH PALBOCICLIB COMPARED WITH LETROZOLE COMBINED WITH PALBOCICLIB IN PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER

Keywords: Oncology (Adult);
Study Type: Clinical Trial   |  Region: Hawaii
Active, currently enrolling    Who can join   

EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence

Keywords: Oncology (Adult);
Study Type: Clinical Trial   |  Region: Hawaii
Active, not yet recruiting    Who can join   

A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator’s Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

Keywords: Oncology (Adult);
Study Type: Clinical Trial   |  Region: Hawaii
Enrollment complete    Who can join   

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Keywords: Oncology (Adult); NSABP B-42; Breast Cancer; Breast Neoplasms; Neoplasms by…
Study Type: Clinical Trial   |  Region: California - Northern
12345678910...